Kelechi Ugonna1, Konstantinos Douros2, Colin D Bingle3, Mark L Everard4. 1. Department of Respiratory Medicine, Sheffield Children's Hospital, Sheffield, UK. 2. Third Department of Paediatrics, Attikon Hospital, University of Athens School of Medicine, Athens, Greece. 3. Department of Infection and Immunity, University of Sheffield, Sheffield, UK. 4. School of Paediatrics and Child Health, University of Western Australia, Princess Margaret Hospital, Subiaco, Western Australia, Australia.
Abstract
BACKGROUND: Primary respiratory syncytial virus (RSV) infections are characterized by high levels of IL-8 and an intense neutrophilia. Little is known about the cytokine responses in secondary infections. Preschool children experiencing RSV secondary infections were recruited from the siblings of infants admitted to hospital with RSV acute bronchiolitis. METHODS: Fifty-one infants with acute bronchiolitis (39 RSV positive, 12 RSV negative) and 20 age-matched control infants were recruited. In addition, seven older siblings of infants from the RSV-positive cohort and confirmed RSV infection were recruited. Samples of nasal secretions were obtained using a flocked swab, and secretions extracted using centrifugation. Cytokine bead array was used to obtain levels of interleukin (IL)-17A, IL-8, IL-6, IL-21, and tumor necrosis factor-α. RESULTS: Levels of IL-8 and IL-6 were significantly lower in the RSV-positive siblings compared with the RSV-positive infants. There were no significant differences between levels of the other cytokines in the primary and secondary infections. CONCLUSION: The very high levels of IL-8 and IL-6 response characteristic of the primary RSV infection was not observed in secondary RSV-positive infections and this did not appear to be due to a global reduction in cytokine production.
BACKGROUND:Primary respiratory syncytial virus (RSV) infections are characterized by high levels of IL-8 and an intense neutrophilia. Little is known about the cytokine responses in secondary infections. Preschool children experiencing RSV secondary infections were recruited from the siblings of infants admitted to hospital with RSV acute bronchiolitis. METHODS: Fifty-one infants with acute bronchiolitis (39 RSV positive, 12 RSV negative) and 20 age-matched control infants were recruited. In addition, seven older siblings of infants from the RSV-positive cohort and confirmed RSV infection were recruited. Samples of nasal secretions were obtained using a flocked swab, and secretions extracted using centrifugation. Cytokine bead array was used to obtain levels of interleukin (IL)-17A, IL-8, IL-6, IL-21, and tumor necrosis factor-α. RESULTS: Levels of IL-8 and IL-6 were significantly lower in the RSV-positive siblings compared with the RSV-positive infants. There were no significant differences between levels of the other cytokines in the primary and secondary infections. CONCLUSION: The very high levels of IL-8 and IL-6 response characteristic of the primary RSV infection was not observed in secondary RSV-positive infections and this did not appear to be due to a global reduction in cytokine production.
Authors: A Hornsleth; B Klug; M Nir; J Johansen; K S Hansen; L S Christensen; L B Larsen Journal: Pediatr Infect Dis J Date: 1998-12 Impact factor: 2.129
Authors: Thomas C Mangodt; Mikhaïl A Van Herck; Sara Nullens; José Ramet; Jozef J De Dooy; Philippe G Jorens; Benedicte Y De Winter Journal: Pediatr Res Date: 2015-08-12 Impact factor: 3.756
Authors: Maria Pino; David J Kelvin; Jesus F Bermejo-Martin; Ana Alonso; Vanesa Matías; Alberto Tenorio; Lucia Rico; Jose M Eiros; J Castrodeza; Alfredo Blanco-Quiros; Julio Ardura; Raul Ortiz de Lejarazu Journal: Pediatr Allergy Immunol Date: 2009-02-28 Impact factor: 6.377
Authors: E O Ohuma; E A Okiro; R Ochola; C J Sande; P A Cane; G F Medley; C Bottomley; D J Nokes Journal: Am J Epidemiol Date: 2012-10-11 Impact factor: 4.897
Authors: Ying-Jie Lu; Jane Gross; Debby Bogaert; Adam Finn; Linda Bagrade; Qibo Zhang; Jay K Kolls; Amit Srivastava; Anna Lundgren; Sophie Forte; Claudette M Thompson; Kathleen F Harney; Porter W Anderson; Marc Lipsitch; Richard Malley Journal: PLoS Pathog Date: 2008-09-19 Impact factor: 6.823
Authors: Timothy M Kinyanjui; Thomas A House; Moses C Kiti; Patricia A Cane; David J Nokes; Graham F Medley Journal: PLoS One Date: 2015-09-21 Impact factor: 3.240
Authors: Karen Bohmwald; Nicolás M S Gálvez; Gisela Canedo-Marroquín; Magdalena S Pizarro-Ortega; Catalina Andrade-Parra; Felipe Gómez-Santander; Alexis M Kalergis Journal: Front Immunol Date: 2019-03-18 Impact factor: 7.561
Authors: Yaneisi Vázquez; Liliana González; Loreani Noguera; Pablo A González; Claudia A Riedel; Pablo Bertrand; Susan M Bueno Journal: Front Immunol Date: 2019-06-04 Impact factor: 7.561